Dr. Agarwal's Health Care: NCLT meeting held on scheme of amalgamation

Nclt Scheme FiledStrategic Transactions View source PDF Explain this filing

AGARWALEYE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.1%Reaction day

₹476.00

prior close

₹479.00

announcement price

After-mkt

timing

Nifty Microcap 250market-0.3%+0.4% vs market

Hospital peers, median of 23sector+0.4%-0.3% vs sector

On the reaction day the stock moved 0.4 pts more than Nifty Microcap 250 and 0.3 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.2

10m

-0.2

15m

-0.4

30m

-0.8

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.1-0.3+0.4+0.4-0.3

Next day

+0.6-0.1+0.8-0.1+0.7

-1.3-0.8-0.4-0.4-0.9

+0.4-2.8+3.3-2.9+3.3

+1.9-1.0+2.9-0.6+2.5

+0.6+0.4+0.2-0.7+1.3

+2.3-0.5+2.8-1.6+3.9

15d

+1.2-1.9+3.1-2.0+3.2

+1.3+0.4+0.8-1.9+3.1

+7.2+3.5+3.7-1.2+8.4

+1.6+2.0-0.4-9.4+11.0

UpDownMarket · Nifty Microcap 250Sector · Hospital peers, median of 23Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

NCLT-convened meeting of equity shareholders of Dr. Agarwal's Health Care was held on July 02, 2026 in Chennai to consider the Scheme of Amalgamation of Dr. Agarwal's Eye Hospital Limited (Transferor) with Dr. Agarwal's Health Care Limited (Transferee). Out of 43,122 total shareholders, 47 were present (17 promoters, 30 public). Quorum was met. The special majority resolution under Sections 230-232 of the Companies Act was put to vote via remote e-voting, venue e-voting, and polling papers. Final voting results are awaited as the Scrutinizer was directed to submit a consolidated report.

Likely market impact

Amalgamation of eye hospital arm with listed entity advances; results pending. Successful consolidation could streamline the group structure.